Education
About Us
Working with TipRanks
Follow Us
Logicmark Inc. (LGMK)
OTHER OTC:LGMK
Top Page
LogicMark
(OTC:LGMK)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.85
The score is primarily weighed down by weak financial performance, highlighted by very large losses (net margin -91.72%), negative returns (ROE -54.07%), and negative operating/free cash flow, despite low leverage and a strong gross margin. Technicals are also weak with negative MACD and price below the 50-day average, while valuation cannot be supported from the provided P/E (0.000) and missing dividend yield.
LogicMark (LGMK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$652.46K
Dividend YieldN/A
Average Volume (3M)4.43K
Price to Earnings (P/E)―
Beta (1Y)1.71
Revenue Growth5.27%
EPS Growth99.24%
CountryUS
Employees31
SectorHealthcare
Sector Strength45
IndustrySecurity & Protection Services
Share Statistics
EPS (TTM)-1657.50
Shares Outstanding906,065
10 Day Avg. Volume2,997
30 Day Avg. Volume4,433
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.08
Price to Sales (P/S)0.10
P/FCF Ratio-0.17
Enterprise Value/Market Cap-6.31
Enterprise Value/Revenue-0.39
Enterprise Value/Gross Profit-0.59
Enterprise Value/Ebitda0.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LogicMark Business Overview & Revenue Model
Company DescriptionLogicMark, Inc. offers personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.
How the Company Makes MoneyLogicMark generates revenue primarily through the sale of its PERS products and services, which include subscription models for monitoring and support services. The company sells its devices directly to consumers and through partnerships with healthcare organizations, senior living communities, and government agencies. Significant revenue streams also include recurring subscription fees from customers who opt for ongoing monitoring services, which provide a steady income. Additionally, LogicMark may leverage strategic partnerships with healthcare providers to enhance its distribution channels and expand its market reach, further contributing to its earnings.
LogicMark Earnings Call Summary
Earnings Call Date:Aug 12, 2025
(Q2-2025)
| Next Earnings Date:Aug 18, 2026
Earnings Call Sentiment Neutral
LogicMark demonstrated strong revenue growth and improved financial metrics, driven by successful product launches and a strengthened cash position. However, increased operating expenses and continued net losses present challenges. Uncertainty in government funding remains a concern, though no immediate impact has been seen. The sentiment is balanced between positive growth and financial challenges.Q2-2025 Updates
Positive Updates
Strong Revenue Growth
LogicMark reported a 22% year-over-year revenue growth, marking its strongest pace in recent years, driven by investments in product innovation and team expansion.
Improved Gross Margin
The company achieved a gross margin improvement of 99 basis points to 67.5%, benefiting from a favorable product mix shift towards higher-margin offerings.
Successful Product Launches
Growth was fueled by higher sales of new devices like the Freedom Alert Mini and the upgraded Guardian Alert 911 Plus, which includes features such as AI-enabled fall detection.
Strengthened Financial Position
Completed a registered public offering in the first quarter of 2025, resulting in $14.4 million in gross proceeds, enhancing the company's cash position to $13 million with no long-term debt.
Expansion in Sales Leadership
Appointment of Jeffrey Durkin as SVP of Sales to lead B2B expansion, alongside revitalization of the reseller program and deepening institutional and government channel relationships.
Negative Updates
Increased Operating Expenses
Total operating expenses rose by 12% year-over-year to $4.1 million, driven by recruitment costs and higher consulting and legal fees.
Continued Net Loss
Reported a net loss attributable to common shareholders of $2.1 million for the quarter, unchanged from the same period last year.
Uncertainty in Government Funding
Potential cutbacks and reduced funding to government agencies could impact partnerships, though no slowdown in demand from the VA has been observed yet.
Company Guidance
In the second quarter of 2025, LogicMark reported a robust 22% year-over-year revenue growth, achieving $2.9 million in revenue, driven by increased sales of the Freedom Alert Mini and the upgraded Guardian Alert 911 Plus PERS units. The company's gross profit rose by 24% to $1.9 million, with a gross margin improvement of 99 basis points to 67.5%. Operating expenses increased by 12% to $4.1 million due to recruitment and higher consulting and legal fees. Despite a net loss attributable to common shareholders remaining at $2.1 million, the net loss per share improved significantly from $24.12 last year to no loss or gain per share, attributable to a higher number of common shares. For the first half of 2025, total revenue reached $5.4 million, while net loss per share improved from $45.30 to $0.02. LogicMark strengthened its cash position with a $14.4 million public offering, ending the quarter with $13 million in cash and investments. The company remains focused on expanding its PERS and aging-in-place solutions, driven by strategic sales and marketing efforts, including the recent appointment of Jeffrey Durkin as SVP of Sales.LogicMark Financial Statement Overview
Summary
LogicMark is facing significant financial challenges, with consistent losses impacting its profitability and return metrics. While the company maintains low leverage, its negative cash flows and poor return on equity highlight the need for strategic improvements in operations and cost management to enhance financial stability and shareholder value.Income Statement
LogicMark's income statement shows a slight revenue growth of 2.02% in the TTM period, but the company is struggling with profitability. The gross profit margin is healthy at 66.02%, yet the net profit margin is deeply negative at -91.72%, indicating significant losses. EBIT and EBITDA margins are also negative, reflecting operational challenges. The company needs to address its cost structure to improve profitability.35
Negative
Balance Sheet
The balance sheet reveals a low debt-to-equity ratio of 0.0021, suggesting minimal leverage, which is a positive aspect. However, the return on equity is negative at -54.07%, indicating that the company is not generating returns for its shareholders. The equity ratio is not provided, but the overall financial health appears weak due to persistent losses.40
Negative
Cash Flow
Cash flow analysis shows negative operating cash flow and free cash flow, with a declining free cash flow growth rate of -6.45% in the TTM period. The operating cash flow to net income ratio is negative, indicating cash flow issues. The free cash flow to net income ratio is positive at 1.32, suggesting that despite losses, the company is managing to convert some of its earnings into free cash flow.30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.61M | 9.90M | 9.93M | 11.92M | 10.02M | 11.44M |
| Gross Profit | 6.98M | 6.62M | 6.66M | 7.23M | 5.79M | 8.20M |
| EBITDA | -6.33M | -6.06M | -6.57M | -6.10M | -2.24M | 241.58K |
| Net Income | -9.65M | -9.00M | -14.55M | -6.92M | -11.71M | -2.86M |
Balance Sheet | ||||||
| Total Assets | 22.37M | 14.22M | 17.02M | 25.64M | 30.12M | 26.95M |
| Cash, Cash Equivalents and Short-Term Investments | 11.69M | 3.81M | 6.40M | 6.98M | 12.04M | 4.39M |
| Total Debt | 323.43K | 51.84K | 120.16K | 69.40K | 64.35K | 10.65M |
| Total Liabilities | 2.73M | 2.03M | 2.10M | 2.85M | 1.73M | 15.98M |
| Stockholders Equity | 19.64M | 12.19M | 14.91M | 22.79M | 28.40M | 10.97M |
Cash Flow | ||||||
| Free Cash Flow | -5.31M | -5.72M | -5.69M | -4.92M | -5.91M | -312.96K |
| Operating Cash Flow | -4.41M | -4.25M | -4.32M | -3.61M | -5.91M | -312.96K |
| Investing Cash Flow | -9.03M | -1.46M | -1.37M | -1.31M | 0.00 | 0.00 |
| Financing Cash Flow | 11.97M | 3.12M | 5.05M | -300.00K | 13.63M | 3.11M |
LogicMark Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.